Company Directory / Medical Device

Aleva Neurotherapeutics logo

PrivateFor profitMedical DeviceLausanne, VD, Switzerland

Aleva Neurotherapeutics

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Founded
2008
18 years ago
Staff
51-100
3 on LinkedIn
Followers
5k
on LinkedIn
Funding
$65M
as listed, USD

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their… Read all

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

51-100 people: larger than 75% of companies with a size listed. 3 people list it on LinkedIn.

Age

200819002026

18 years old.

Reach

No web traffic ranking listed. 4,893 followers on LinkedIn.

What it does

Health CareHealth DiagnosticsMedical DeviceNeuroscienceNeurosurgeryDeep Brain StimulationMedical Device Development

What it is known for

neurosurgerydeep brain stimulationmedical device developmentmedical equipment manufacturingeuropean medical deviceneurostimulationneurosurgeon toolsdirectional deep brain stimulationimplantable pulse generatorbrain electrode designprogrammable neurostimulatorssurgical precisionbrain implant technologypersonalized therapyprecision neuromodulationmedical device r&d

What its website runs on

WixMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft 365Microsoft 365 Apps & ServicesMicrosoft ExchangeCloudFlareGoogle App EngineHREF LangWebsiteBuilderSirvoyTrustArcGoogle MapsPriority Hintspickadate.jsWordPress.orgPrimeNG

Funding, as listed

$65M raised in total

  • Rounds9
  • LatestCorporate round, Jul 2021
  • Latest amountUSD 1,091,890
  • Investors11, 7 leading

What the source datasets report. We have not watched these rounds ourselves.

Annual revenue$2.5M
FoundersAndré Mercanzini, Claudio Pollo, Jean-Pierre Rosat, Paul Pyzowski, Philippe Renaud
NAICS33911

Every detail we hold

Everything the source datasets list about Aleva Neurotherapeutics, field by field. Contact details are held but never shown.

The company

Name
Aleva Neurotherapeutics
Type
For profit
Status
Private
Founded
2008
Founders
André Mercanzini, Claudio Pollo, Jean-Pierre Rosat, Paul Pyzowski, Philippe Renaud
Industry
Medical Device
Categories
Health Care, Health Diagnostics, Medical Device, Neuroscience
Specialities
Neurosurgery, Deep Brain Stimulation, Medical Device Development

Where

City
Lausanne
Region
VD
Country
Switzerland
Markets
Europe, Middle East, and Africa (EMEA)

Size and reach

Staff band
51-100
People on LinkedIn
3
LinkedIn followers
4,893
Annual revenue
$2.5M

Funding, as listed

Total
$65,268,508 USD
Rounds
9
Latest round
Corporate round
Latest round date
Jul 2021
Latest amount
1,091,890 USD
Investors
11
Lead investors
7
Listing status
private

Classification

NAICS
33911
SIC
3844
Keywords
16 listed, shown above
Technologies
18 detected, shown above

About this record

Sources
Crunchbase, LinkedIn, Apollo
Last imported
Sept 2026

Growth, as the source summarises it

Aleva Neurotherapeutics may be growing due to the expanding market for deep brain stimulation (DBS) devices, which is relevant to their proprietary neurostimulation platform based on microDBS technology. The global DBS devices market is projected to reach a valuation of USD 3.44 billion by 2033, growing at a CAGR of 10.22%, which suggests a growing demand for products in the same category as Aleva's offerings. Additionally, the underutilization of Parkinson's DBS treatments in the UK indicates potential for market expansion and increased adoption of such technologies. The overall expansion of the DBS devices market to an estimated USD 3.5 billion by 2033 further supports the potential for growth in the sector where Aleva Neurotherapeutics operates.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Medical Device in Switzerland.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.